Coronavirus: German/US vaccine candidate cleared for Phase 2 and 3 clinical trials
The coronavirus vaccine candidate was approved for a global trial of 30,000 participants, according to the CEO of Biontech, Ugur Sahin. Biotechnology…
Jul 30, 2020
Coronavirus: German/US vaccine candidate cleared for Phase 2 and 3 clinical trials
The coronavirus vaccine candidate was approved for a global trial of 30,000 participants, according to the CEO of Biontech, Ugur Sahin. Biotechnology…
Jul 30, 2020